NCT06726226

Brief Summary

This study examines the respiratory outcomes of preterm infants born at gestational ages less than 29 weeks, spanning from birth to 24 months corrected age. It delves into the intricacies of respiratory function impairment attributable to diverse factors, such as respiratory distress syndrome, bronchopulmonary dysplasia, postnatal corticosteroids, ventilatory support, as well as nutritional aspect during NICU stay. Furthermore, it scrutinizes the incidence of chronic respiratory diseases stemming from these conditions, assessing their long-term impact on respiratory prognosis post-discharge. In addition to respiratory aspects, the research extends its focus to the growth and developmental outcomes of preterm infants. By synthesizing these multifaceted elements, the study aspires to enhance current treatments and preventative measures for respiratory conditions in preterm infants.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
46mo left

Started Jun 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress51%
Jun 2022Feb 2030

Study Start

First participant enrolled

June 1, 2022

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

January 16, 2024

Completed
11 months until next milestone

First Posted

Study publicly available on registry

December 10, 2024

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2030

Last Updated

December 10, 2024

Status Verified

December 1, 2024

Enrollment Period

7.8 years

First QC Date

January 16, 2024

Last Update Submit

December 4, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Postprematurity respiratory disease

    1. Severe * ≥2 respiratory hospitalizations, * home supplemental O2 after 3 months or any home mechanical ventilation, * systemic steroid exposure or pulmonary vasodilators, or symptoms despite -inhaled corticosteroid use 2. Mild to moderate * one hospitalization * home oxygen \<3 months corrected age or tracheostomy without ventilation, * any inhaled corticosteroid or bronchodilator exposure, or symptoms in ≥2 questionnaires 3. No/minimal - all other cases 1\. Respiratory medications 2. Hospitalizations for cardiopulmonary cause 3. Coughing, wheezing, or other respiratory symptoms 4. Home technology dependence

    12 months of corrected age

Secondary Outcomes (3)

  • Growth assessment

    at 24 months of corrected age

  • Any delay in developmental scale evaluation

    at 24 months of corrected age

  • Long-term respiratory outcome

    at 6 years of corrected age

Study Arms (1)

Respiratory cohort

Preterm infants with a gestational age less than 29 weeks

Other: Standard care for preterm infants

Interventions

Standard care for preterm infants according to the institutional protocol

Respiratory cohort

Eligibility Criteria

AgeUp to 7 Days
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

This study is a multicenter cohort study conducted by a total of 7 institutions (Seoul National University Hospital, Severance Hospital, Asan Medical center, Samsung Medical Hospital, Ajou University Hospital, Bundang Seoul National University Hospital, Chonnam National University Hospital) jointly. It includes all preterm infants born at these hospitals from March 2022 to December 2024, who are born at a gestational age of less than 29 weeks and are admitted to the neonatal intensive care unit.

You may qualify if:

  • Infants born at gestational age less than 29 weeks with cohort consent obtained within 7 days of birth

You may not qualify if:

  • death within 3 days of birth
  • severe structural heart defects
  • structural abnormalities in the upper airway, lungs, or chest
  • congenital anomalies that may impact cardiopulmonary function
  • follow-up is difficult until 24 months of age

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seung Han Shin

Seoul, 110-744, South Korea

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

1. Transtracheal aspirate Collection Timing: Immediately after registration, 3(±1) days after the first collection, 14(±2) days after birth, and 28(±2) days after birth. 2. Urine Collection Timing: Immediately after registration, 3(±1) days after the first collection, 14(±2) days after birth, and 28(±2) days after birth.

MeSH Terms

Conditions

Premature BirthRespiration Disorders

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Seung Han Shin, MD, PhD

    Seoul National University Children's Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Seung Han Shin, MD, PhD

CONTACT

Gyeong Eun Yeom, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
6 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 16, 2024

First Posted

December 10, 2024

Study Start

June 1, 2022

Primary Completion (Estimated)

February 28, 2030

Study Completion (Estimated)

February 28, 2030

Last Updated

December 10, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations